(Q50288651)

English

Inactivation of over-expressed wild type EGFR by Cetuximab recombinant antibody

An instance of the biological reaction in Homo sapiens with Reactome ID (R-HSA-1248677)

In more languages

Statements

biological process

1 reference

8 July 2022

Inhibition of Signaling by Overexpressed EGFR

1 reference

8 July 2022

1 reference

8 July 2022

https://identifiers.org/reactome:R-HSA-1248677

1 reference

8 July 2022

epidermal growth factor receptor

1

object has role

1 reference

8 July 2022

EGFR:Cetuximab [plasma membrane]

1

object has role

1 reference

8 July 2022

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

8 July 2022

Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study

1 reference

8 July 2022

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

1 reference

8 July 2022

Identifiers

1 reference

8 July 2022

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50288651&oldid=2110617280"